Cancer Protein May Help Brain Clear Alzheimer's Plaques

Scientists may have solved a medical mystery that's puzzled doctors for years: why people with a history of cancer are less likely to develop Alzheimer's disease.

A groundbreaking study published in the journal Cell shows that certain cancers release a protein called cystatin-C that travels through the bloodstream and enters the brain. Once there, it does something remarkable: it helps clear away the harmful amyloid plaques that cause Alzheimer's symptoms.

The protein works like a cleanup crew for the brain. Cystatin-C binds to the toxic amyloid clumps and activates TREM2, a protein that acts like an on-switch for the brain's immune cells. Those immune cells then get to work removing existing plaques, which improved cognitive function in the study's mouse models.

Dr. Bob Arnot, a Vermont-based internal medicine physician, explains that doctors have observed this "inverse comorbidity" pattern for years. "People with a history of cancer are less likely to develop Alzheimer's disease, and people with Alzheimer's are less likely to develop cancer," he told Fox News Digital.

What makes this discovery especially exciting is where it could lead. Most Alzheimer's treatments struggle to reach the brain effectively, but this study identifies a natural pathway that already gets there. The findings suggest a specific biological mechanism that researchers could target for future treatments.

The Bright Side

This isn't just another study about preventing Alzheimer's in healthy people. The research points toward treatments that could help patients who already have established disease by clearing existing plaques, not just preventing new ones from forming.

Dr. Arnot emphasized an important point: the study doesn't suggest cancer itself is protective or desirable. "Instead, it reveals that biological programs activated during cancer can inadvertently engage protective immune mechanisms in the brain," he said.

The research team used mouse models for their experiments, so scientists still need to confirm whether the same effects occur in humans. But the discovery opens a promising new avenue for developing treatments that could actually reverse some of the brain damage caused by Alzheimer's.

For the millions of families affected by Alzheimer's disease, this research offers something that's been in short supply: genuine hope for treatments that don't just slow decline, but actively help the brain heal.